medigraphic.com
ISSN 1726-6718 (Electronic)
Revista Cubana de Anestesiología y Reanimación

2020, Number 2

<< Back Next >>

Revista Cubana de Anestesiología y Reanimación 2020; 19 (2)

Systemic ozone therapy in insulin-dependent diabetic patients with neuropathic pain

Pérez GY, Lombas RA

Language: Spanish
References: 31
Page: 1-10
PDF size: 413.09 Kb.


ABSTRACT

Introduction: Frequently, diabetic patients present neuropathic pain as a complication of their disease.
Objective: To identify the advantages of systemic ozone therapy for insulin-dependent diabetic patients with neuropathic pain.
Methods: A descriptive study was carried out with insulin-dependent diabetic patients with neuropathic pain who attended the Pain Clinic of Hermanos Ameijeiras Clinical-Surgical Hospital between February 2014 until January 2019. All of them were quantified pain, the presence of paresthesias, muscle strength, ankle jerk reflex, and glycosylated hemoglobin. The patients received fifteen sessions of rectal ozone and six sessions of major self-hemotherapy. We compared the outcomes after the first session and after the last one (eight weeks).
Results: 45.3% were 60 years or older, 59% were female, and 89.3% had a natural history of diabetes of 15 years or more. In the first hospital visit, the intensity of 100% pain ranged between 7 and 10 according to the verbal numeric scale, and all presented paresthesias. In 59.3%, there was a decrease in muscle strength, 62% had decreased ankle jerk reflex, and 88% had glycosylated hemoglobin higher than or equal to 12%. These symptoms improved at week eight.
Conclusions: The proven analgesic and anti-inflammatory properties of ozone make it currently a therapeutic tool among the most efficient for controlling chronic pain in insulin-dependent diabetic patients.


REFERENCES

  1. Watson JC, Sandroni P. Central neuropathic pain syndromes. Mayo Clin Proc. 2016 [acceso: 25/05/2019];91(3):372-85. Disponible en: https://www.mayoclinicproceedings.org/ article/S0025-6196(16)00073-2/fulltext

  2. Pérez C, Ribera MV, Gálvez R, Micó JA, Barutell C, FaildeI, et al. High prevalence of confirmed, butalsoof potential and believed, neuropathic pain in pain clinics. Eur J Pain. 2013[acceso: 25/05/2019];17(3):347-356. Disponible en: http://doi.org/10.1002/j.1532-2149.2012.00204.x

  3. Samper Bernal D, Monerris Tabasco MM, Homs Riera M, Soler Pedrola M. Etiologi´a y manejo de la neuropati´a diabe´tica dolorosa. Rev Soc Esp Dolor. 2010[acceso: 25/05/2019];17(6):286-98. Disponible en: http://scielo.isciii.es/pdf/dolor/v17n6/revision_ mbe2.pdf

  4. Harrison RA, Field TS. Post stroke pain: identification, assessment, and therapy. Cerebrovasc Dis. 2015[acceso: 25/05/2019];39(3-4):190-201. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/25766121

  5. Lopes de Jesus CC, Dos Santos FC, de Jesus LMOB, Monteiro I, Sant'Ana MSSC, Trevisani VFM. Comparison between intra-articular ozone and placebo in the treatment of knee osteoarthritis: A randomized, double-blinded, placebo-controlled study. PLoS One. 2017[acceso: 25/05/2019];12(7):e0179185. Disponible en: https://journals.plos.org/plosone/ article/comments?id=10.1371/journal.pone.0179185

  6. Hidalgo-Tallón FJ, Torres LM. Ozonoterapia en medicina del dolor. Revisión. Rev Soc Esp Dolor. 2013[acceso: 25/05/2019];20(6):291-300. Disponible en: http://scielo.isciii.es/ scielo.php?script=sci_arttext&pid=S1134-80462013000600003

  7. Stephen J, Thomas-Meaders BS, Muto M, Murphy KJ. A metaanalysis of the effectiveness and safety of ozone treatments for herniated lumbar discs. J. Vascular and Interventional Radiology. 2010[acceso: 25/05/2019];21(4):534-48. Disponible en: https://www.jvir.org/article/S1051-0443(09)01668-6/fulltext

  8. Alvarado Güémez F, Lima Hernández LB, Núñez Lima C, Lima González S. Aplicación de microdosis de ozono en pacientes portadores de dolor o daños neurológicos. Reporte de 67 casos. Rev Esp Ozonoterapia. 2016[acceso: 25/05/2019];6(1):89-110. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=5506711

  9. Baeza Nochi J. Revisión WFOT (Review on Evidence Based Ozone Therapy). Ozonoterapia Basada en Evidencias (Versión 1 oficial en Español del documento WFOT's). World Federation of Ozone Therapy. Madrid. 2015. pp 44-52.

  10. Alvarado Güémez F, Lima Hernández LB, Núñez Lima C, Lima González S. Tratamiento de Sacroilitis mediante aplicación de inyecciones intraarticulares de ozono. Reporte de 75 casos. Revista Española de Ozonoterapia. 2018[acceso: 25/05/2019];8(1):65-85. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=6554688

  11. Scwartz A, Martínez Sánchez G. La ozonoterapia y su fundamentación científica. Rev Española Ozonoterapia. 2012[acceso: 25/05/2019];2(1):163-198. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=3915917

  12. Bocci V, Zanardi I, Maya SP. Diabetes and chronic oxidative stress. A perspective based on the possible usefulness of ozone therapy. Diabetes Metab Syndr. 2011[acceso: 25/05/2019];5(1):45-49. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/22814842

  13. Bocci V. Ozone as a biorregulator: Pharmacology and toxicology of ozonotheraphy. J Biol Reg. 2010[acceso: 25/05/2019];31(10):213. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/9250885

  14. Schiavon F, Circhetta C, Dani L. The diabetic hand. Rheumatism. 2010;56(3):139-42.

  15. Park S, Hyeon-Ji Kang, Jae-Han Jeon, Min-Ji Kim. Recent advances in the pathogenesis of microvascular complications in diabetes. Archives of Pharmacal Research. 2019[acceso: 25/05/2019];42(3): 252-62. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/30771210

  16. Heitmann H, Biberacher V, Tiemann L. Prevalence of neuropathic pain in early multiple sclerosis. Mult Scler J. 2016[acceso: 25/05/2019];22(9):1224-30. Disponible en: https://journals.sagepub.com/doi/abs/10.1177/1352458515613643?journalCode=msja

  17. Piconi L, Quaglioro L, Ceriello A. Oxidative stress in diabetes. Clin Chem Lab Med. 2013;41(9):1144-49.

  18. Ceriello A. Posprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes. 2005[acceso: 25/05/2019];54(1):1-7. Disponible en: https://diabetes. diabetesjournals.org/content/54/1/1

  19. Clapés S, Armas D, Marquetty A, Lemani M, Márquez I, Díaz D, et al. Disminución de la capacidad antioxidante en niños y adolescentes diabéticos. Rev Cubana Invest Biomed. 2006[acceso: 25/05/2019];25(2):1-7. Disponible en: http://scielo.sld.cu/scielo.php?script= sci_arttext&pid=S0864-03002006000200001&lng=es

  20. Aghadavod E, Khodadadi S, Baradaran A, Nasri P, Bahmani M, Rafieian-Kopaei M. Role of oxidative stress and inflammatory factors in diabetic kidney disease, Iranian J Kidney Diseases. 2016[acceso: 25/05/2019];10(6):337-43. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/27903991

  21. Díaz D. Hiperglicemia y Estres Oxidativo en el paciente diabético. Rev Cubana Invest Biomed. 2006[acceso: 25/05/2019];25(3):1-9. Disponible en: http://scielo.sld.cu/scielo.php? script=sci_arttext&pid=S0864-03002006000300009&lng=es

  22. Sasaki S, Inoguchi T. The role of oxidative stress in the pathogenesis of diabetic vascular complications. Diabetes Metab J. 2012[acceso: 25/05/2019];36(4):255-261. Disponible en: http://doi.org/10.4093/dmj.2012.36.4.255

  23. Murphy K, Elias G, Steppan J, Boxley C, Balagurunathan K, Victor X, et al. Percutaneous treatment of herniated lumbar discs with ozone: investigation of the mechanisms of action. J Vasc Interventional Radiology. 2016[acceso: 25/05/2019];27(8):1242-50. Disponible en: https://www.jvir.org/article/S1051-0443(16) 30046-X/fulltext

  24. Ahmed N, Babaei-Jadidi R, Howell SK, Beisswenger PJ, Thornalley PJ. Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes. Diabetologia. 2005[acceso: 25/05/2019];48(8):1590-1603. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/15988580

  25. Schaefer C, Mann R, Sadosky A. Burden of illness associated with peripheral and central neuropathic pain among adults seeking treatment in the United States: a patient-centered evaluation. Pain Med. 2014[acceso: 25/05/2019];15(12):2105-19. Disponible en: https://www.scholars.northwestern.edu/en/publications/burden-of-illness-associated-with-peripheral-and-central-neuropat

  26. Inoguchi T, Natawa H. NAD (P)H oxidase activation: A potential target mechanism for diabetic vascular complications, progressive beta-cell dysfunction and metabolic syndrome. Curr Drug Targets. 2005[acceso: 25/05/2019];6(4):495-501. Disponible en: https://www.semanticscholar.org/paper/NAD(P)H-oxidase-activation%3A-a-potential-target-for-Inoguchi-Nawata/afbb37f7fde9b79dffa9723c9abfefee9515cf6b

  27. Al-Dallen SM, Chávez T, Martínez G, Ferreira E, León OS. El equilibrio redox en la diabetes y sus complicaciones. Acta Farm Bonaerense. 2004[acceso: 25/05/2019];23(2):231-42. Disponible en: http://www.sedici.unlp.edu.ar/handle/10915/6647

  28. Forrester SJ, Kikuchi DS, Hernandes MS, Xu Q, Griendling KK. Reactive oxygen species in metabolic and inflammatory signaling. Circulation Research 2018[acceso: 25/05/2019];122(6):877-902. Disponible en: https://www.ahajournals.org/doi/abs/10.1161/ circresaha.117.311401

  29. Frank GD, Equchi S, Motley ED. The role of reactive oxygen species in insulin signaling in the vasculature. Antioxid Redox Signal. 2005[acceso: 25/05/2019];7(7-8):1053-61. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/15998260

  30. Bays H. Atherogenic dyslipidaemia in type 2 diabetes and metabolic syndrome: current and future treatment options. Br J Diabetes Vasc Dis. 2003[acceso: 25/05/2019];3(5):356-60. Disponible en: https://journals.sagepub.com/doi/abs/10.1177/14746514030030050801

  31. Miceli L, Bednarova R, Paduano R, Romano M, Bove T. Management of chronic pain in Italy: proposal for specific priority criteria. Ig Sanita Pubbl. 2018[acceso: 25/05/2019];74(6):543-45. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/31030212




2020     |     www.medigraphic.com